United Kingdom-based GW Pharmaceuticals posted marginal revenue growth in the second quarter over the previous quarter, citing challenges stemming from the COVID-19 pandemic. GW reported revenue of $121.3 million for the quarter ended June 30 – about the same as the previous period. GW’s quarterly net loss rose slightly to $8.8 million. By product, Epidiolex […]
You may also like
About the author
Steve serves as the founding editor of Hemp Stash News. With over 10 years experience in the news publishing business he decided to extend his vast portfolio by editing and publishing news about the Cannabis industry. Steve has a bachelor's degree in Journalism from the Northern Arizona University.
Steve can be reached out at: Steve.Morrison@hempstashnews.com